Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 197,078 | 43,277 | 35,622 | 33,358 | 124,968 |
| Marketable Securities | 244,035 | 408,303 | 417,481 | 439,662 | 406,752 |
| Receivables | 26,735 | 16,697 | 19,669 | 18,054 | 13,876 |
| Inventories | 6,326 | 7,061 | 6,543 | 3,565 | 3,321 |
| TOTAL | $485,099 | $489,971 | $494,428 | $508,651 | $562,330 |
| Non-Current Assets | |||||
| PPE Net | 2,136 | 2,227 | 2,317 | 2,508 | 2,285 |
| Intangibles | 18,020 | 18,815 | 19,610 | 20,405 | 15,630 |
| Other Non-Current Assets | 2,572 | 2,767 | 2,682 | 2,792 | 2,543 |
| TOTAL | $22,728 | $23,809 | $24,609 | $25,705 | $20,458 |
| Total Assets | $507,827 | $513,780 | $519,037 | $534,356 | $582,788 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,733 | 5,778 | 5,090 | 2,540 | 3,262 |
| Accrued Expenses | 54,615 | 48,210 | 44,131 | 43,641 | 68,625 |
| TOTAL | $60,522 | $56,466 | $51,221 | $47,879 | $73,451 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,000 | 2,317 | 1,847 | 1,636 | 1,554 |
| Other Non-Current Liabilities | 3,103 | 3,493 | 3,611 | 3,615 | 3,353 |
| TOTAL | $6,143 | $6,446 | $6,982 | $6,965 | $6,586 |
| Total Liabilities | $66,665 | $62,912 | $58,203 | $54,844 | $80,037 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,298 | 102,676 | 102,432 | 101,363 | 101,355 |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -661,403 | -640,125 | -620,399 | -590,077 | -554,081 |
| Other shareholders' equity | 65 | 69 | -92 | -52 | 84 |
| TOTAL | $441,162 | $450,868 | $460,834 | $479,512 | $502,751 |
| Total Liabilities And Equity | $507,827 | $513,780 | $519,037 | $534,356 | $582,788 |